利用CRISPR/Cas9构建G6PD基因c.1388G>A突变的HEK293/K562细胞株

该文旨在利用CRISPR/Cas9构建G6PD基因c.1388GA突变的HEK293/K562细胞株,为G6PD缺陷症及其修复研究提供细胞模型。针对G6PD基因c.1388GA位点设计单链向导RNA(sg RNA)与突变同源臂,利用CRISPR/Cas9联合同源重组修复(HDR)构建G6PD基因c.1388GA突变的HEK293细胞株与红白血病K562细胞株; qRT-PCR、Western blot检测G6PD基因表达; CCK8检测细胞增殖;G6PD/6PGD比值法检测G6PD酶活性;结晶紫染色与Annexin V-APC/7-AAD验证突变细胞株对氧化活性药物维生素K3与伯安喹的耐受情况。结果显示,成功构建CRISPR/Cas9双质粒载体系统;筛选单克隆细胞经测序鉴定显示,成功构建G6PD基因c.1388GA突变的HEK293与K562细胞株,且无脱靶;进一步发现, c.1388GA突变不影响HEK293与K562细胞G6PD基因mRNA转录与蛋白翻译,但细胞增殖减慢, G6PD酶活性下降;突变HEK293细胞对维生素K3与伯安喹的耐受力减弱,突变K562细胞对伯安喹耐受能力减弱。该研究成功构建G6PD基因c.1388GA突变的HEK293与K562细胞株,为G6PD缺陷症及后期基因修复研究提供细胞模型。     

十字花科黑腐病菌中葡萄糖-6-磷酸脱氢酶的酶学分析

葡萄糖-6-磷酸脱氢酶是磷酸戊糖途径(HMP)的限速酶,在十字花科黑腐病菌8004的基因组中,有2个基因XC1977和XC4082被注释为葡萄糖-6-磷酸脱氢酶(G6PD)。前期工作发现XC1977突变后,细胞的胞外多糖产量明显降低,而XC4082突变不影响胞外多糖产量。为明确这两个基因的编码产物在Xcc中的生化功能,本工作表达纯化了这两个蛋白,并对这两个蛋白的特征进行分析,发现这两个蛋白均具有6-葡萄糖脱氢酶的活性,但是它们的最适反应温度、最适反应pH、金属离子和烷化剂的敏感性完全不同。而且,XC1977以NAD~+和NADP~+为电子受体,而XC4082只能以NADP~+为电子受体。在以NAD~+和NADP~+为受体时,XC1977的K_m值分别为0.125 mmol/L和0.927 mmol/L,而XC4082以NADP~+为受体时的K_m值为0.364 mmol/L。这表明Xcc细胞合成胞外多糖时,需要NAD~+参与能量代谢。     

应用易错PCR技术提高环糊精葡萄糖基转移酶的可溶性表达

【目的】对嗜热脂肪芽孢杆菌CHB1的环糊精葡萄糖基转移酶(CGTase)基因进行定向进化,筛选得到胞外酶活性和可溶性表达定量提高的突变酶。【方法】采用易错PCR技术向环糊精葡萄糖基转移酶基因中随机引入突变,建立酶基因突变文库,筛选获得胞外酶活性和可溶性表达定量提高的突变体,并对突变酶进行诱导表达、纯化及部分酶学性质研究。【结果】通过筛选获得CGTase胞外酶活性和可溶性表达定量提高的突变菌株ds-6和ep-9,其胞外α-环化活力分别是原始酶的1.72倍和2.18倍,可溶性表达量提高了1倍。序列分析表明,突变体ep-9有3个碱基发生了变化:G2005A/A2037G/T2081G,其中有2个碱基突变导致了氨基酸的改变。SWISS-MODEL数据库模拟CGTase的结构表明,2个突变氨基酸分别位于无规卷曲和β-转角/折叠之间的转角中。酶学性质测定表明:突变CGTase的β-环化比活力是原始酶的2.44倍,总环化比活力提高了34%,K_m值由4.3 g/L降低到3.74 g/L;在pH稳定性方面较原始酶有所提高。单碱基定点突变证实突变体ep-9可溶性表达水平及胞外酶活性提高的关键突变是G2005A。【结论】本试验表明:基于易错PCR技术获得嗜热芽孢杆菌CHB1的CGTase的胞外酶活和可溶性表达定向进化,G2005A突变对于提高CGTase的可溶性表达及胞外酶活起关键作用,这对认识CGTase的构效关系以及进一步改造该酶分子、扩大酶的生产应用具有重要意义。     

一个蚕豆病遗传家系G6PD基因突变及X染色体失活偏移检测

对一蚕豆病遗传家系的G6PD基因突变进行分析,检测突变后G6PD酶活变化,并对先证者家系进行X染色体失活（XCI）偏移模式检测,从而预测G6PD突变女性携带者患蚕豆病的风险。取家系成员的外周血样,并提取基因组DNA,用聚合酶链式反应（PCR）和DNA测序法进行序列分析,确定先证者突变位点和突变类型及家庭成员遗传情况,若先证者的母亲和姐姐为G6PD突变携带者,则对先证者母亲和姐姐进行X染色体偏移检测以及酶活检测分析,以评估携带者患蚕豆病的风险,同时对研究对象进行随访。结果患者X染色体上G6PD基因发生点突变c.1376G>T;酶活性检测结果显示该突变使G6PD酶活性下降大约25%,导致蚕豆病发生。该家系的两位女性携带者X染色体失活偏移<80%,未来发生蚕豆病的可能性低。     

一例Hb Ottawa[αl5(A13)Gly→Arg]的化学结构分析

本文报道在一个8岁汉族女孩血液中发现一种慢速异常血红蛋白。家系调查结果显示,异常基因来自其母。取患者静脉血制备珠蛋白,然后分离异常肽链,进行异常肽链的胰蛋白酶酶解物指纹图谱分析和异常肽段的氨基酸定量分析。结果证明血红蛋白α链第15位甘氨酸被精氨酸所取代,该变异体是Hb Ottawa(α15(A13)G1y→Arg)。本例异常血红蛋白在国内系首次发现。     

人G6PD T279A和T279S两种突变子的体外构建

目的:构建葡萄糖6磷酸脱氢酶(Glucose 6-phosphate dehydrogenase,G6PD)T279A和T279S两种突变子.方法:以Genbank No X03674为参考序列设计并合成引物、以含G6PD基因的质粒(Philip JMason博士惠赠)为模板,PCR扩增获得G6PD野生型基因片段,琼脂糖凝胶电泳后回收PCR产物,连接、转化构建克隆质粒pMD18T-G6PD;酶切pMD18T-G6PD质粒、电泳后回收目的基因片段,连接、转化构建含G6PD野生型基因的重组质粒pAL-G6PD;设计并合成含有突变序列的引物,以pAL-G6PD为模板,体外扩增获得G6PD835-海口(835A→G,T279A)和835-中国-1(835 A→T,T279S)突变子.结果:酶切后经电泳鉴定表明获得与预期大小相符的pMD18T-G6PD质粒,EcoRI和Hind Ⅲ双酶切获得与预期大小相符的pAL-G6PD,测序结果与参考序列完全一致.0.8%的琼脂糖凝胶电泳鉴定,并定量pAL-G6PD单链DNA浓度约为200ng/uL.经测序鉴定并与参考序列比对结果表明获得了G6PD的T279A和T279S两种突变子.结论:成功构建了G6PD的T279A和T279S两种突变子,为下一步原核表达、生化性质以及酶动力学等研究奠定了基础.     

人双专一性磷酸酶活性位点Cys^124附近精氨酸突变及功能

为研究人双专一性磷酸酶活性位点Cys12 4 附近 3个带正电的精氨酸对酶催化功能的影响 ,用QuikChange定点突变方法获得 6个突变体 :R12 5L、R130 L、R130 K、R130 L/S131A、R158K和R158L。将含突变基因的重组质粒转化大肠杆菌菌株BL2 1(DE3) ,经IPTG诱导表达获得的目的蛋白质均以可溶形式存在。通过镍离子亲和层析纯化得到纯度大于 90 %的蛋白质。对人痘苗病毒H1相关磷酸酶 (VHR)及其突变体进行稳态动力学参数和竞争性抑制常数Ki 的测定 ,结果显示上述Arg130 和Arg158突变体的kcat/Km 值都较野生型有大幅度下降 ,而Ki 值有明显上升 ,表明 130和 15 8位的精氨酸是VHR活性所必需 ,而且可能与底物上带负电的磷酸基团结合有关。另外 ,单突变体R130 L和双突变体R130 L/S131A之间的kcat值相差很小 ,提示Arg130 单点突变后可能破坏了Ser131与Cys12 4 间的氢键。再者 ,R12 5L、R130 L和R158L突变体都降低了砷酸盐结合亲和性 ,暗示这 3个精氨酸残基侧链上的正电荷可能有助于底物与酶的结合。     

不同地区HPV16 E7基因的克隆及序列差异分析

采用PCR扩增、pGEM T载体克隆和核苷酸序列分析的方法对一例武汉地区及两例五峰县高发区宫颈癌患者体内HPV16型的E7基因编码区进行序列分析并与野生型 (德国标准株 )及已发表的HPV16湖北株 (HPVHB)进行了比较。结果发现武汉地区HPV16型E7基因仅第 5 4位出现一个同义突变 ,而高发区HPV16型E7基因存在差异 ,第 77位氨基酸由精氨酸 (Arg)变为半胱氨酸 (Cys) ,第 96位由谷氨酰氨酸 (Gln)变为精氨酸 (Arg) ,E7蛋白的二级结构及亲、疏水性也相应改变 ,与野生型有较大差异     

云南阿昌族G6PD基因突变G487A在DF213中的表达

为获得阿昌族G6PDWT和G6PDG487A重组蛋白,研究G6PDG487A的结构和功能改变,从云南省德宏州梁河县杞木寨乡湾中村阿昌族聚集地的G6PD缺陷家系先证者和正常阿昌族个体全血提取RNA,经RT-巢式PCR得cDNA,将cDNA克隆至pMD18-Tsimple载体中并测序;错配碱基经定点突变修复后,目的基因亚克隆至pThioHis(A)载体,构建了阿昌族G6PD基因野生型和G487A突变型原核表达载体:pThioHis(A)-AChang-G6PDWT和pThioHis(A)-AChang-G6PDG487A。用重组质粒转化E.coli Competent Cells DF213(G6PD defeciency),经IPTG诱导G6PD表达、10%SDS-PAGE电泳检测表达蛋白和紫外340nm定量测定G6PD活性的分析表明,pThioHis(A)-AChang-G6PDWT和pThioHis(A)-AChang-G6PDG487A在DF213中成功表达,分子量约为59kDa。IPTG诱导0、3、6、9、和12h后,G6PD活性逐渐增高,G6PD基因WT表达的酶活性约是G487A的20-25倍。表达载体的构建以及G6PDcDNA在DF213中成功表达,为重组酶G6PDG487A的进一步研究奠定了基础。     

不同地区HPV16E7基因的克隆及序列差异分析

采用PCR扩增、pGEM-T载体克隆和核苷酸序列分析的方法对一 例武汉地区及两例五峰县高发区宫颈癌患者体内HPV16型的E7基因编码区进行序列分析并与 野生型(德国标准株)及已发表的HPV16湖北株(HPVHB)进行了比较.结果发现武汉地区HPV16 型E7基因仅第54位出现一个同义突变,而高发区HPV16型E7基因存在差异,第77位氨基酸由 精氨酸(Arg)变为半胱氨酸(Cys),第96位由谷氨酰氨酸(Gln)变为精氨酸(Arg),E7蛋白的二级 结构及亲、疏水性也相应改变,与野生型有较大差异.     

Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population

A systematic study on the structure and function of Glucose-6-phosphate dehydrogenase (G6PD) variations was carried out in China. A total of 155,879 participants were screened for G6PD deficiency by the G6PD/6PGD ratio method and 6,683 cases have been found. The prevalence of G6PD deficiency ranged from 0 to 17.4%. With informed consent, 1,004 cases from 11 ethnic-based groups were subjected to molecular analysis. Our results showed the followings: (1) The G6PD variants are consistent across traditional ethnic boundaries, but vary in frequencies across ethnic-based groups in Chinese population, (2) The G6PD variants in Chinese population are different from those in African, European, and Indian populations, (3) A novel G6PD-deficiency mutation, 274C→T, has been found, and (4) Denaturing high performance liquid chromatography is of great advantage to detecting G6PD-deficient mutations for diagnosis and genetic counseling. Moreover, functional analysis of the human G6PD variants showed the following: (1) The charge property, polarity, pK-radical and side-chain radical of the substituting amino acid have an effect on G6PD activity, (2) The G6PDArg459 and Arg463 play important roles in anchoring NADP⁺ to the catalytic domain to maintain the enzymatic activity, and (3) The sequence from codon 459 to the carboxyl terminal is essential for the enzymatic function.     

Glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from Lactobacillus casei: responses with different modulators

Glucose 6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (6PGD) were separated and partially purified from glucose-grown cells of Lactobacillus casei. The enzymes had similar pH optima, thermosensitivity and molecular weights. They had different net charges and their pI values were 5.38 and 4.52, respectively. Histidine, arginine, lysine and cysteine residues were essential for the activity of G6PD, and all the above amino acids with the exception of lysine were required for 6PGD activity. Mg2+ activated 6PGD up to 15 mM concentration, above which it was inhibitory. It had no effect on G6PD activity. G6PD was specific for NADP+, but 6PGD showed some activity with NAD+ as the cofactor, although it was essentially NADP(+)-preferring. Both the enzymes, were inhibited by NADPH. 6PGD was also inhibited by its product, ribulose 5-phosphate. ATP inhibited 6PGD only at subsaturating concentrations of NADP+. The inhibition was sigmoidal in the absence of Mg2+ and hyperbolic in its presence.     

Molecular heterogeneity underlying the G6PD Mediterranean phenotype

Summary As part of a study aiming to define the molecular basis of glucose-6-phosphate dehydrogenase (G6PD) deficiency, we analysed a sample from a Portugese boy with a family history of favism. Although the biochemical properties of red-cell G6PD from this subject were similar to those of the common variant G6PD Mediterranean, the corresponding mutation (563 CT) was not present. Instead, polymerase chain reaction (PCR) amplification and sequencing of the entire gene detected a CT transition at nucleotide 592 in exon VI, changing an arginine residue to a cysteine residue only 10 amino acids downstream from the Mediterranean mutation. Single-strand conformation polymorphism analysis of a PCR-amplified DNA fragment spanning exons VI and VII of the G6PD gene has detected the same mutation, confirmed by sequencing, in a G6PD-deficient patient from Southern Italy. We name this new variant G6PD Coimbra.     

G6PD Ferrara I has the same two mutations as G6PD A(-) but a distinct biochemical phenotype

The cloning and sequencing of the normal glucose-6-phosphate dehydrogenase (G6PD) gene has led to the study of the molecular defects that determine enzymatic variants. In this paper, we describe the mutations responsible for the Ferrara I variant in an Italian man with a family history of favism, from the Po delta. Nucleotide sequencing of this variant showed a GA mutation at nucleotide 202 in exon IV causing a ValMet amino acid exchange, and a second AG mutation at nucleotide 376 in exon V causing an AsnAsp amino acid substitution. Although on the basis of its biochemical properties this variant was classified as G6PD Ferrara I, it has the same two mutations as G6PD A(-), which is common in American and African blacks, and as the sporadic Italian G6PD Matera. The mutation at nucleotide 202 was confirmed by NlaIII digestion of a polymerase chain reaction amplified DNA fragment spanning 109 bp of exon IV. The 109-bp mutated amplified sequence is not distinguishable from the normal sequence in single strand conformation polymorphism analysis.     

Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica

Summary Glucose-6-phosphate dehydrogenase (G6PD) deficiency has previously been reported among both the black and white populations of Costa Rica. All 28 G6PD A — samples were found to be of the common G6PD A-^376G/202Atype. A previously described mutation associated with nonspherocytic hemolytic anemia, G6PD Puerto Limón, was found to be due to a GA transition at nucleotide (nt) 1192, causing a glulys substitution. Mutations in this region of the G6PD molecule seem invariably to be associated with chronic hemolytic anemia. G6PD Santamaria had been described previously in two unrelated white subjects. We found that both did, indeed, have the same mutations. In this variant the AG substitution at nt 376 that is characteristic of G6PD A was present, but an AT mutation at nt 542, apparently superimposed on the ancient G6PD A mutation, resulted in an aspval substitution. Thus, the gain of a negative charge at amino acid 126 was counterbalanced by the loss of a charge at amino acid 181, giving rise to a variant with the G6PD A mutation but with normal electrophoretic mobility.     

Molecular identification of mutations in G6PD gene in patients with favism in Iran

Glucose 6-phosphate dehydrogenase is a highly polymorphic enzyme encoded by a human X-linked gene (Xq2.8). This enzyme catalyses the first step of pentose phosphate pathway, that converts glucose 6-phosphate to 6-phosphogluconate with production of NADPH2. G6PD deficiency is the most common human metabolic inborn error affecting more than 400 million people world wide. The main clinical manifestations are acute hemolytic anemia and jaundice, triggered by infection or ingestion of Fava beans or oxidative drugs. A predominant variant of G6PD named Mediterranean is often associated with favism. This has been evident in several countries including Northern coastal provinces of Iran. Other current variants are Chatham and Cosenza. Molecular identification of the most prevalent mutations in G6PD gene was carried out in 71 males and females with G6PD deficiency. They were from Iranian Northern province of Golestan. DNA was extracted from blood samples and analyzed for known G6PD mutation by PCR and restriction fragment length polymorphisms (RFLP) technique. Adapting this method, revealed that Mediterranean mutation at nt 563(C-->T) is predominant in the area (69%) and 26.7% of patients have Chatham mutation at nt 1003(G-->A). Findings indicate a higher prevalence of these mutations, in Golestan compared to Mazandaran (66.2% Mediterranean and 19% Chatham mutation) and Gilan (86.4% Mediterranean and 9.71% Chatham mutations). Cosenza mutation at nt 1376(G-->C), by PCR-RFLP technique was not found among other 3 samples (4.3%). The similarity of these results with mutations in Italy indicates probable existence of a common ancestral origin in the observed populations.     

Glucose-6-phosphate dehydrogenase (G6PD) Iserlohn and G6PD Regensburg: two new severe enzyme defects in German families

Two new inheritable variants of glucose-6-phosphate dehydrogenase have been found in two unrelated German families. Patients with one variant (G6PD Iserlohn, also referred to as G6PD I) suffered from intermittent hemolytic crises caused by fava beans; patients with the other variant (G6PD Regensburg, G6PD II) disclosed chronic nonspherocytic hemolytic anemia aggravated by drug treatment. Due to their unusual biochemical characteristics, the new variants were designated G6PD Iserlohn and G6PD Regensburg. Both variants showed a reduction of enzyme activity to about 6% of the normal in erythrocytes, normal electrophoretic mobility, increased affinity for glucose-6-phosphate, a reduced affinity for NADP and a pH optimum in the neutral region (7.0 and 7.5). G6PD Iserlohn had a decreased affinity for the inhibitor NADPH; G6PD Regensburg had a normal inhibitor constant. Deamino NADP was utilized at an increased rate by G6PD Regensburg. G6PD Iserlohn was thermostable, G6PD Regensburg mildly instable. G6PD activity in leukocytes was normal in G6PD Iserlohn and reduced to the same degree as in erythrocytets in G6PD Regensburg. The cause of the decreased activity of G6PD Iserlohn appears to be in vivo instability; in G6PD Regensburg further mechanisms might include reduced specific activity or reduced synthesis of the variant enzyme.     

Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress.

Glucose 6-phosphate dehydrogenase (G6PD) is a housekeeping enzyme encoded in mammals by an X-linked gene. It has important functions in intermediary metabolism because it catalyzes the first step in the pentose phosphate pathway and provides reductive potential in the form of NADPH. In human populations, many mutant G6PD alleles (some present at polymorphic frequencies) cause a partial loss of G6PD activity and a variety of hemolytic anemias, which vary from mild to severe. All these mutants have some residual enzyme activity, and no large deletions in the G6PD gene have ever been found. To test which, if any, function of G6PD is essential, we have disrupted the G6PD gene in male mouse embryonic stem cells by targeted homologous recombination. We have isolated numerous clones, shown to be recombinant by Southern blot analysis, in which G6PD activity is undetectable. We have extensively characterized individual clones and found that they are extremely sensitive to H2O2 and to the sulfydryl group oxidizing agent, diamide. Their markedly impaired cloning efficiency is restored by reducing the oxygen tension. We conclude that G6PD activity is dispensable for pentose synthesis, but is essential to protect cells against even mild oxidative stress.     

DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants

Over 400 supposedly biochemically and genetically distinct variants of glucose-6-phosphate dehydrogenase (G6PD) have been described in the past. In order to investigate these variants at the DNA sequence level we have now determined the relevant sequences of introns of G6PD and describe a method which allows us to rapidly determine the sequence of the entire coding region of G6PD. This technique was applied to six variants that cause G6PD deficiency to be functionally so severe as to result in nonspherocytic hemolytic anemia. Although the patients were all unrelated, G6PD Marion, Gastonia, and Minnesota each had identical mutations, a G----T at nucleotide (nt) 637 in exon 6 leading to a Val----Leu substitution at amino acid 213. The mutations of Nashville and Anaheim were identical to each other, viz. G----A at nt 1178 in exon 10 producing a Arg----His substitution at amino acid 393. G6PD Loma Linda had a C----A substitution at nt 1089 in exon 10, producing a Asn----Lys change at amino acid 363. The results confirm our earlier results suggesting that the NADP-binding site is in a small region of exon 10 and suggest the possibility that this area is also concerned with the binding of glucose-6-P.